Correlation Between Kiora Pharmaceuticals and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Neurobo Pharmaceuticals.
Diversification Opportunities for Kiora Pharmaceuticals and Neurobo Pharmaceuticals
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kiora and Neurobo is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 0.65 times more return on investment than Neurobo Pharmaceuticals. However, Kiora Pharmaceuticals is 1.54 times less risky than Neurobo Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.48 per unit of risk. If you would invest 358.00 in Kiora Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 45.00 from holding Kiora Pharmaceuticals or generate 12.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 15.0% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| Neurobo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kiora Pharmaceuticals and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and Neurobo Pharmaceuticals
The main advantage of trading using opposite Kiora Pharmaceuticals and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |